Plasma amino acid profiling improves predictive accuracy of adverse events in patients with heart failure.

Simple measurement of 3-Me-His with either β-alanine or valine improved the predictive ability for adverse events, indicating the utility of plasma amino acid profiling in risk stratification of hospitalized HF patients.